Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-2-8
pubmed:abstractText
Cardiovascular implantable electronic device (CIED) infection rates are increasing faster than implantation rates. More effective antimicrobial prophylaxis may help reduce CIED infections and improve clinical outcomes. The AIGIS(Rx)(®) antibacterial envelope is a polymer mesh implanted in the generator pocket with the CIED. After implantation it releases two antibiotics, minocycline and rifampin, that have been shown to reduce infections associated with other medical devices. The purpose of this retrospective cohort study is to determine the rate of CIED implantation success and CIED infection in procedures utilizing the antibacterial envelope.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1540-8159
pubmed:author
pubmed:copyrightInfo
©2010, The Authors. Journal compilation ©2010 Wiley Periodicals, Inc.
pubmed:issnType
Electronic
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
133-42
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope.
pubmed:affiliation
Emory University, Atlanta and the Atlanta VA Medical Center, Decatur, Georgia 30322, USA. hbloom@emory.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study